Agent for increasing hyaluronic acid levels
Cypress water-based hyaluronic acid increasing agent addresses the decline in skin moisture retention by promoting hyaluronic acid production in the epidermis, particularly in dry conditions, improving skin hydration and reducing aging effects.
Patent Information
- Application Number
- JP2023074935
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2023-04-28
- Publication Date
- 2024-11-08
AI Technical Summary
The skin barrier weakens due to factors such as dryness, ultraviolet rays, and aging, leading to a decrease in hyaluronic acid in skin cells, particularly in the epidermis, necessitating measures to improve moisture retention.
A hyaluronic acid increasing agent containing cypress water as an active ingredient, which is applied topically to increase hyaluronic acid levels in the epidermis, especially in dry conditions.
Cypress water effectively promotes hyaluronic acid production in the skin, particularly in dry conditions, enhancing skin moisture retention and reducing signs of aging like wrinkles and photoaging.
Smart Images

Figure 2024159140000001_ABST
Abstract
Description
[Technical field]
[0001] The present invention relates to a hyaluronic acid increaser. [Background technology]
[0002] In the skin epidermis, components such as intercellular lipids, NMF, and cornified envelopes cover the skin surface, acting as a skin barrier and preventing water evaporation. Hyaluronic acid not only forms this covering on the skin surface, but also plays a role in retaining moisture from within the skin as a component of the extracellular matrix of skin cells such as epidermal cells and dermal cells.
[0003] However, the skin barrier weakens due to factors such as dryness, ultraviolet rays, aging, external stimuli, etc. In particular, when the humidity of the outside air is low, the skin dries out from the surface, so measures are required not only to prevent the surface layer from drying out by the skin barrier, but also to increase hyaluronic acid in skin cells, particularly in epidermal cells located directly under the skin barrier, thereby improving the moisture retention function.
[0004] Patent Document 1 discloses hinokitiol as a substance that has a dermal hyaluronic acid production promoting effect when combined with astaxanthin. Patent Document 2 discloses that an oily component extracted from the seeds of the Cupressaceae family, Acanthus arborescens, using an organic solvent has an epidermal hyaluronic acid production promoting effect. [Prior art documents] [Patent documents]
[0005] [Patent Document 1] JP 2011-63563 A [Patent Document 2] Patent No. 5913118 Summary of the Invention [Problem to be solved by the invention]
[0006] An object of the present invention is to provide a hyaluronic acid increaser. [Means for solving the problem]
[0007] As a result of extensive research into various ingredients, the present inventors have discovered that cypress water is particularly effective as an agent for increasing hyaluronic acid in the skin, and have thus completed the following invention: (1) A hyaluronic acid increaser containing cypress water as an active ingredient. (2) A hyaluronic acid increaser according to (1) for increasing hyaluronic acid in the epidermis. (3) The hyaluronic acid increasing agent described in (2), wherein the epidermis is in a dry state. (4) A composition for application to skin, comprising the hyaluronic acid increaser according to any one of (1) to (3). (5) A cosmetic method for increasing hyaluronic acid in a subject in need thereof, comprising applying cypress water to the skin of the subject. (6) The method according to (5) for increasing hyaluronic acid in the epidermis of the subject. (7) The method according to (6), wherein the epidermis is in a dry state. Effect of the Invention
[0008] Application of the hyaluronic acid increaser of the present invention can promote hyaluronic acid in the skin. [Brief description of the drawings]
[0009] [Figure 1] FIG. 1 shows CD44 and HABP in the cases where cypress water (5.0% by weight) was added or water was added (control). DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0010] Patent Document 1 discloses hinokitiol as a substance that has the effect of promoting dermal hyaluronic acid production in combination with astaxanthin, but the effect of hinokitiol alone has not been confirmed.Patent Document 2 discloses that the oily component extracted from the seeds of Cupressaceae, Acanthus arborescens, using an organic solvent has the effect of promoting epidermal hyaluronic acid production, but although the use of the oily component extracted using an organic solvent is permitted as a cosmetic raw material, it is not necessarily desirable depending on the skin condition.
[0011] The present invention provides a hyaluronic acid increaser containing cypress water as an active ingredient. In addition, since cypress water is derived from a water extract of the natural cypress, it is also preferred in that it is less irritating to the skin.
[0012] Hyaluronic acid is a mucopolysaccharide with a molecular weight of about 800,000 to 2 million, in which N-acetylglucosamine and D-glucuronic acid are linked in a linear chain. Hyaluronic acid is widely present in the body, such as in the skin and cartilage, and plays a role in moisturizing the skin, but it is known to decrease due to ultraviolet rays and aging.
[0013] The increase in hyaluronic acid can be measured by, for example, the increase in the amount of hyaluronic acid in skin samples when a hyaluronic acid enhancer is applied, compared to the state (control) in which no hyaluronic acid enhancer is applied.The increase in the amount of hyaluronic acid can be confirmed, for example, by visually confirming the increase in the amount of hyaluronic acid, or the amount of hyaluronic acid markers such as hyaluronic acid receptors (e.g., CD44, etc.), hyaluronic acid binding protein HABP, etc., or by calculating the amount of increase and determining the increase with a statistically significant difference (e.g., Student's t-test) with a significance level of 5%, or the increase rate, for example, 5% or more, 10% or more, 20% or more, 30% or more, etc.The amount of hyaluronic acid markers such as CD44 and HABP can be measured by immunostaining, ELISA, etc.
[0014] Such an increase in hyaluronic acid can be measured by various methods including in vivo, in vitro, ex vivo, etc. For example, the skin sample used in the present invention is not limited as long as the amount of hyaluronic acid or its marker in the skin can be measured. For example, the skin sample may be a skin sample after collection, for example, a skin sample in an ex vivo state after collection from an animal such as a human, or an artificial skin sample such as a 3D skin model can be used. For example, cultured skin cells collected from an animal such as a human, for example, monolayer or multilayer cultured cells, cultured keratinocytes, cultured fibroblasts, or their passaged cells, established cells, etc. can be used.
[0015] The cypress water used in the present invention is an aqueous phase obtained by steam distillation of a water extract obtained by extracting with water from the trunks and / or branches of cypress (Chamaecyparis obtusa Siebold et Zuccarini), and meets the specifications of "Cypress Water" as specified in the Quasi-Drug Ingredients Standards 2006 (Quasi-Drug Ingredients Standards 2006). Cypress water is produced based on the production method described in the "Origin" of the "Cypress Water" standard. It is also readily available as a commercial product.
[0016] In a specific embodiment, the agent of the present invention contains cypress water as an active ingredient, for example, 10% by mass or more, 20% by mass or more, 30% by mass or more, 40% by mass or more, 50% by mass or more, 60% by mass or more, 70% by mass or more, 80% by mass or more, 90% by mass or more, 95% by mass or more, or 99% by mass or more. In another embodiment, the agent of the present invention consists of cypress water.
[0017] The present inventors have also discovered that the present invention increases hyaluronic acid in the epidermis, particularly in dry conditions. Therefore, the hyaluronic acid increaser of the present invention may be an agent for increasing hyaluronic acid in the epidermis, particularly in dry conditions.
[0018] Dry conditions refer to low humidity in the outside air. For example, in one embodiment, the humidity is 40% RH or less, 30% RH or less, 20% RH or less, or 10% RH or less at temperatures between -10°C and 50°C, preferably between 0°C and 50°C, and more preferably between 10°C and 40°C. For example, in one embodiment, the humidity is 20% RH or less at temperatures between 20°C and 40°C, for example, 37°C.
[0019] The agent of the present invention may be contained in compositions such as medicines, quasi-drugs, cosmetics, etc. The composition of the present invention may be a composition for increasing epidermal hyaluronic acid in skin, such as epidermis, especially under dry conditions.The composition of the present invention may be a composition for moisturizing skin, such as epidermis, especially under dry conditions by increasing epidermal hyaluronic acid, especially under dry conditions.
[0020] The amount of cypress water in the composition of the present invention can be appropriately determined depending on the type, purpose, form, method of use, etc. For example, in the case of external administration, the amount of cypress water can be 0.001 to 100 wt%, 0.005 to 75 wt%, 0.01 to 50 wt%, 0.05 to 25 wt%, 0.1 to 20 wt%, 0.5 to 15 wt%, 1.0 to 10.0 wt%, 2.5 to 5.0 wt%, etc., based on the total weight of the composition of the present invention.
[0021] The hyaluronic acid increaser or composition of the present invention can be used with any additive selected as necessary. The additive can include an excipient, etc.
[0022] The excipient may be any one that is normally used when the desired dosage form is prepared, and examples thereof include starches such as wheat starch, rice starch, corn starch, potato starch, dextrin, and cyclodextrin, crystalline celluloses, sugars such as lactose, glucose, sugar, reduced maltose, starch syrup, fructooligosaccharides, and emulsified oligosaccharides, and sugar alcohols such as sorbitol, erythritol, xylitol, lactitol, and mannitol. These excipients may be used alone or in combination of two or more.
[0023] Other additives may be appropriately selected from known additives such as colorants, preservatives, thickeners, binders, disintegrants, dispersants, stabilizers, gelling agents, antioxidants, surfactants, preservatives, pH adjusters, oils, water, alcohols, chelating agents, silicones, ultraviolet absorbers, moisturizers, fragrances, various medicinal ingredients, preservatives, and neutralizing agents.
[0024] In addition to the above components, if necessary, components typically used in skin topicals such as cosmetics, pharmaceuticals, and quasi-drugs, such as antioxidants, oils, UV protection agents, surfactants, thickeners, alcohols, powder components, colorants, aqueous components, water, various skin nutrients, etc., can be appropriately blended as needed within the range that does not impair the effects of the present invention.
[0025] The agent or composition of the present invention may be applied by any route, such as oral, transdermal, or intravenous administration. However, from the viewpoint of increasing hyaluronic acid in the skin, transdermal application is preferred. For example, it can be applied to skin under dry conditions. When applied to the skin, it can be applied as cosmetics, quasi-drugs, etc., particularly preferably as cosmetics, and its form is not limited, and it can be any of solution system, solubilized system, emulsion system, powder dispersion system, water-oil two-layer system, water-oil-powder three-layer system, ointment, lotion, gel, aerosol, etc. When used as cosmetics, it may be used in the form of, for example, face cream, massage cream, body cream, milky lotion, lotion, beauty essence, gel, pack, cleansing cream, hand cream, lotion, foundation, lipstick, lip balm, hand powder, body shampoo, bath cosmetics, etc. If it is an external preparation, it can be used in various forms such as lotion, suspension, emulsion, solution, ointment, patch, etc. However, the form that the agent and composition of the present invention can take is not limited to the above.
[0026] The frequency of application can be selected arbitrarily, such as once every 4 weeks, once every 2 weeks, once a week, once every 3 days, once every 2 days, once a day, twice a day, three times a day, four times a day, five times a day, or application as needed, but is not limited to these.
[0027] The present invention also provides a method for moisturizing the skin in a subject, comprising applying cypress water or the agent or composition of the present invention to a subject in need thereof.In one embodiment of the present invention, a method for moisturizing by increasing epidermal hyaluronic acid in a subject, comprising applying cypress water or the agent or composition of the present invention to a subject in need thereof, is also provided.In one embodiment of the present invention, a method for moisturizing in dry conditions, comprising applying cypress water or the agent or composition of the present invention to a subject in need thereof, is also provided.Moisturizing in dry conditions may be due to increasing epidermal hyaluronic acid in a subject in dry conditions.
[0028] In one embodiment, the subject in need is a mammal, including a human, and preferably a human subject. The subject may be a subject in which dry skin is objectively or subjectively recognized, or a subject in which dry skin is desired to be prevented. For example, the subject may be a subject determined to have low skin moisture, or may be a subject in an environment in which the skin is prone to dryness, such as an environment exposed to dry conditions or ultraviolet light.
[0029] The method of the present invention is a method for cosmetic purposes and may not be a medical procedure such as treatment of a disease or treatment by a doctor or medical professional. Such cosmetic methods may be performed privately or in a beauty salon, a cosmetics store, an esthetic salon, etc.
[0030] Furthermore, the present invention also provides the use of Hinoki water in the manufacture of a medicine for moisturizing the skin, such as the epidermis, especially by increasing epidermal hyaluronic acid under dry conditions, especially moisturizing under dry conditions.The present invention also provides Hinoki water for moisturizing the skin, such as the epidermis, especially by increasing epidermal hyaluronic acid under dry conditions, especially moisturizing under dry conditions. EXAMPLES
[0031] The present invention will now be described in more detail with reference to examples, although the present invention is not limited thereto.
[0032] Sample preparation The cypress water was produced based on the manufacturing method described in the "Origin" section of the "External Raw Materials Standards for Cypress Water" in the Standards for Quasi-Drug Ingredients 2006. More specifically, the liquid obtained by steam distillation of an extract obtained by extracting with water from the trunks and / or branches of cypress (Chamaecyparis obtusa Siebold et Zuccarini) was used as the cypress water.
[0033] Cultivation of skin models The skin model was purchased from MatTek Life Sciences, Inc., and pre-cultured overnight in the medium included with EPI-200 under conditions of 37°C and 100% RH. The medium was replaced with the medium included with EPI-200 containing cypress water at a final concentration of 5.0% by weight, and cultured for 24 hours at 37°C, 100% RH or 20% RH. After 24 hours, the medium was replaced and cultured for another 24 hours. The hyaluronic acid was measured using the skin model cultured in this way. As a control, a skin model prepared in the same manner as above was used, except that the same amount of water was used instead of the cypress water.
[0034] Measurement of hyaluronic acid The skin model was fixed by adding 1 mL of 4% paraformaldehyde to the cell culture insert and leaving it at 4℃ overnight. After that, the dehydration, degreasing, and paraffin infiltration processes were automatically performed in a single processing tank using a closed automatic fixation embedding device, Tissue Tech VIP™ 6AI (Sakura Finetech Japan Co., Ltd.), and then the skin model sample was fixed with paraffin wax to create a paraffin block. Paraffin sections were cut to a thickness of 7 μm from the paraffin block. The sections were treated with 5% bovine serum albumin (Fuji Film Co., Ltd.)-phosphate buffer (PBS(-))-0.05% Tween 20 (PBS-T) (Nacalai Tesque Co., Ltd.) to prevent nonspecific antibody reactions. The primary antibody reaction was performed using anti-CD44 antibody (F10-44-2) (sc-52535, Santa Cruz Co., Ltd.). After the primary antibody reaction, the excess antibody was washed away with PBS-T, and the secondary antibody reaction was performed. The secondary antibodies used were anti-mouse IgG-Alexa488 goat IgG antibodies (A11001, Thermo Fisher). After the secondary antibody reaction, excess antibodies were removed with PBS-T. After staining, the specimens were observed using a fluorescent microscope. The sections were reacted with 3% hydrogen peroxide for 5 minutes to eliminate endogenous peroxidase. After that, nonspecific antibody reactions were prevented with phosphate buffer (PBS(-))-0.05% Tween 20 (PBS-T) (Nacalai Tesque) containing 5% bovine serum albumin (Fujifilm). The primary antibody reaction was performed using hyaluronic acid binding protein HABP (BC41, Hokudo). After the primary antibody reaction, excess antibody was washed away with PBS-T, and the secondary antibody reaction was performed. The secondary antibody used was streptavidin Horseradish Peroxidase Conjugate (02517-61, Nacalai Tesque). After the secondary antibody reaction, excess antibody was removed with PBS-T. A color reaction was performed with DAB chromogen (K3468, Dako) and visualization was performed. Observation was performed using an optical microscope.
[0035] result The results are shown in Figure 1. As shown in Figure 1, the addition of cypress water increased CD44 and HABP. In particular, the increase in HABP was significant at 20% RH. Therefore, an increase in hyaluronic acid is expected, especially under dry conditions. [Industrial Applicability]
[0036] By applying the hyaluronic acid increaser of the present invention, it is possible to increase the hyaluronic acid of skin, especially epidermis.When the hyaluronic acid in skin increases, it is possible to moisturize the skin, and it is expected to suppress the skin aging caused by dryness, such as wrinkles and photoaging.In addition, the moisturizing effect of the present invention has the advantage that it is particularly exhibited under dry conditions.
Claims
1. A hyaluronic acid increaser that contains cypress water as an active ingredient.
2. The hyaluronic acid increaser according to claim 1 for increasing hyaluronic acid in the epidermis.
3. The hyaluronic acid increasing agent according to claim 2 , wherein the epidermis is in a dry state.
4. A composition for application to the skin, comprising the hyaluronic acid increaser according to any one of claims 1 to 3.
5. 1. A cosmetic method for increasing hyaluronic acid in a subject in need thereof, comprising: A method comprising applying cypress water to the skin of a subject.
6. The method of claim 5 for increasing hyaluronic acid in the epidermis of the subject.
7. The method of claim 6 , wherein the epidermis is in a dry state.
Citation Information
Patent Citations
Cosmetic composition containing steam distillate of plant
JP2001220312A
Skin care preparation
JP2003104831A
Fragrant cosmetic composition
JP2003192568A
Cosmetic composition for improving atopic dermatitis comprising steam extracts of Chamaecyparis obtusa and Dendropanax morbifera as active ingredients
KR1020170100245A
Collagen production promoter, hyaluronan production promoter, fibroblast proliferation promoter, and Anti-wrinkle agent
WO2012057123A1
